1. Home
  2. RVPH vs AXIL Comparison

RVPH vs AXIL Comparison

Compare RVPH & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • AXIL
  • Stock Information
  • Founded
  • RVPH 2006
  • AXIL 2015
  • Country
  • RVPH United States
  • AXIL United States
  • Employees
  • RVPH N/A
  • AXIL N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • AXIL Package Goods/Cosmetics
  • Sector
  • RVPH Health Care
  • AXIL Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • AXIL Nasdaq
  • Market Cap
  • RVPH 32.8M
  • AXIL 36.5M
  • IPO Year
  • RVPH N/A
  • AXIL N/A
  • Fundamental
  • Price
  • RVPH $0.40
  • AXIL $5.06
  • Analyst Decision
  • RVPH Strong Buy
  • AXIL
  • Analyst Count
  • RVPH 5
  • AXIL 0
  • Target Price
  • RVPH $9.00
  • AXIL N/A
  • AVG Volume (30 Days)
  • RVPH 3.0M
  • AXIL 13.5K
  • Earning Date
  • RVPH 08-13-2025
  • AXIL 08-14-2025
  • Dividend Yield
  • RVPH N/A
  • AXIL N/A
  • EPS Growth
  • RVPH N/A
  • AXIL 93.65
  • EPS
  • RVPH N/A
  • AXIL 0.29
  • Revenue
  • RVPH N/A
  • AXIL $27,007,463.00
  • Revenue This Year
  • RVPH N/A
  • AXIL N/A
  • Revenue Next Year
  • RVPH N/A
  • AXIL N/A
  • P/E Ratio
  • RVPH N/A
  • AXIL $17.62
  • Revenue Growth
  • RVPH N/A
  • AXIL N/A
  • 52 Week Low
  • RVPH $0.30
  • AXIL $3.54
  • 52 Week High
  • RVPH $4.28
  • AXIL $10.75
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 34.18
  • AXIL 40.91
  • Support Level
  • RVPH $0.35
  • AXIL $4.84
  • Resistance Level
  • RVPH $0.83
  • AXIL $5.30
  • Average True Range (ATR)
  • RVPH 0.06
  • AXIL 0.47
  • MACD
  • RVPH -0.01
  • AXIL -0.02
  • Stochastic Oscillator
  • RVPH 18.68
  • AXIL 16.20

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About AXIL AXIL Brands Inc. Common Stock

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.

Share on Social Networks: